// App-Quantinova.ai

750 : Nanoliposomal targeting of Ephrin receptor A2 (EphA2): Clinical translation

Researchers

Presenter

  • Walid S. Kamoun

Principal Investigators

  • Shinji Oyama

  • Tad Kornaga

  • Theresa Feng

  • Lia Luus

  • Minh T. Pham

  • Dmitri B. Kirpotin

  • James D. Marks

  • Melissa Geddie

  • Lihui Xu

  • Alexey A. Lugovskoy

  • Monica Murphy

  • Carl Morrisson

  • Daryl C. Drummond

Medical Centers

  • Merrimack, Cambridge, MA

  • UCSF, San Francisco, CA

  • Roswell Park Cancer Institute, Buffalo, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • MM310

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A